Re: That was one sweet day of trading....
|
2
|
Resverlogix Corp.
|
Aug 02, 2018 09:53AM
|
Re: why on earth
|
2
|
Resverlogix Corp.
|
May 13, 2024 03:55PM
|
Re: RVXs up or down draft from ZENE???
|
2
|
Resverlogix Corp.
|
Jan 11, 2024 12:35AM
|
Re: Just got off the phone with my brokerage...this might be interesting
|
2
|
Resverlogix Corp.
|
Apr 22, 2019 12:43PM
|
Re: Gilead's GS-5829 flops in mCRPC
|
2
|
Zenith Epigenetics
|
Jul 19, 2022 04:42PM
|
Re: WHY
|
2
|
Resverlogix Corp.
|
Oct 10, 2019 01:16PM
|
Re: Questions about units
|
2
|
Resverlogix Corp.
|
May 17, 2019 11:23AM
|
Re: Groundwork for Future Trials
|
2
|
Resverlogix Corp.
|
Oct 02, 2019 03:48PM
|
Re: Anyways Gran Oso.....
|
2
|
Resverlogix Corp.
|
Jul 31, 2019 09:42PM
|
Re: Chemical probes targeting epigenetic proteins: Applications beyond oncology
|
2
|
Resverlogix Corp.
|
Aug 05, 2017 02:25AM
|
Re: No update yet from stockwatch....
|
2
|
Resverlogix Corp.
|
Jun 06, 2018 02:30PM
|
Re: Total Shares Outstanding 10/15/20
|
2
|
Resverlogix Corp.
|
Oct 16, 2020 05:21PM
|
Re: Breakthrough Therapy Designation
|
2
|
Resverlogix Corp.
|
Jun 13, 2023 12:26PM
|
Re: ZHCLF
|
2
|
Zenith Epigenetics
|
Jul 22, 2022 04:35PM
|
Re: Finance
|
2
|
Resverlogix Corp.
|
Dec 11, 2019 09:42PM
|
Re: The latest numbers for Alberta.
|
2
|
Resverlogix Corp.
|
Sep 14, 2021 11:58PM
|
Re: Safety and Efficacy
|
2
|
Resverlogix Corp.
|
Mar 03, 2017 12:03AM
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
2
|
Resverlogix Corp.
|
Jun 23, 2020 02:22AM
|
Re: Anyways Gran Oso.....
|
2
|
Resverlogix Corp.
|
Jul 31, 2019 11:06PM
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
2
|
Resverlogix Corp.
|
Nov 15, 2022 12:21PM
|